Fantastic new video from @parkinsons.org.uk showcasing some of the research funded from identifying what causes Parkinson's through to developing new therapies #causetocure youtu.be/jj9ZmkcZl2o

Research

YouTube video by Parkinson's UK

youtu.be

Can your organisation help us build a depressed mood mission map? It’s part of our new project, the Mental Health Catalyst. The goal is to enable field-wide strategic collaboration and accelerate progress in mental health research. Find out more ⤵️

Join the mental health team at Wellcome as a Research Lead, Implementation and help bridge the gap between development of innovative solutions and their application in real world settings: Salary: £82,100 Closing date:  Monday, 24 March 2025   wellcome.wd3.myworkdayjobs.com/en-US/Wellco...

Call to action in mental health science

Niall Boyce@nboyce.bsky.social · last yr.

"The best response to criticism of our field is not words, but rather positive results." @lynseyb.bsky.social and me in the BJPsych on how to build a better future for mental health science. www.cambridge.org/core/journal...

Coming soon - a new @wellcometrust.bsky.social funded Generative AI for Mental Health Research Accelerator - aiming to support foundational research on the application of generative AI to improve measurement of and intervention in anxiety, depression, & psychosis. Learn more - mexa.app/accelerator

I'm delighted to say our highly secure and productive OpenSAFELY platform has received a further £17 million in funding from Wellcome, including for a new mental health data project. More here, and clips from Today on Radio4 this morning too! www.bennett.ox.ac.uk/blog/2025/02...

Game-changing new funding from Wellcome for OpenSAFELY and mental health data | Bennett Institute for Applied Data Science

This morning the Today programme on Radio 4 did two great spots on OpenSAFELY.

bennett.ox.ac.uk

Our new target validation funding call is now live! @wellcometrust.bsky.social aims to support validation of novel targets relevant for anxiety, depression and psychosis. wellcome.org/grant-fundin... Join us for the webinar at 13:00 GMT on 25th Feb - wellcome-org.zoom.us/webinar/regi...

Mental Health Award: Advancing target validation - Funding | Wellcome

This call will provide funding for validation activities for novel targets with a clear therapeutic concept and strong biological rationale related to early intervention in anxiety, depression and/or ...

wellcome.org

@wellcometrust.bsky.social commissioned a report into the opportunities and barriers to using sensor-based digital health technologies for mental health research and clinical practice datacc.dimesociety.org/mental-healt...

Advancing the Use of Digital Measures for Mental Health - DATAcc by DiMe

Together, we are using a consensus approach to identify the key aspects of early symptom development in people with mental health and provide insight into which sDHTs are the most appropriate for capt...

datacc.dimesociety.org

New MHRA guidance out to support manufacturers navigate medical device regulations in the UK and protect users of digital mental health technologies: www.gov.uk/government/n...

Digital mental health technologies guidance launched to help manufacturers and safeguard users

New guidance helps manufacturers navigate medical device regulations and protect users of digital mental health technologies.

gov.uk

Fantastic to see the launch of the new @wellcometrust.bsky.social funded MAMS platform for Treatment Resistant Depression: www.charite.de/en/service/p...

Coming soon - @wellcometrust.bsky.social funding to unlock the potential of longitudinal datasets and develop innovative ways of identifying anxiety, depression and/or psychosis early wellcome.org/grant-fundin... More info coming soon

Longitudinal studies | Grant funding | Wellcome

Wellcome are funding research teams to analyse longitudinal data to help identify mental health conditions early. See eligibility information and find out how to apply.

wellcome.org

@wellcometrust.bsky.social wants to help find better pharmacological treatments for mental health. That’s why it’s funding novel target validation proposals related to early intervention in anxiety, depression and/or psychosis. Sign up to be notified and register for the webinar in post below ⤵️

Mental Health Award: Advancing target validation - Funding | Wellcome

This call will provide funding for validation activities for novel targets with a clear therapeutic concept and strong biological rationale related to early intervention in anxiety, depression and/or ...

wellcome.org

🚀 Calling all visionary scientists and engineers! Announcing our call for Focused Research Organization proposals in the UK. 🔬Submit your concept paper by Feb 7 & full proposal by March 28. More here: www.convergentresearch.org/frost-uk ⤵️

Exciting range of precision neurotechnology projects funded through ARIA some of which are being trialled in mental health: www.aria.org.uk/opportunity-...

Precision Neurotechnologies

Backed by £69m, this programme aims to unlock new methods to interface with the human brain at the cellular level, with unprecedented precision.

aria.org.uk

The only 'Blue Monday' article you'll ever need theneuroscienceofeve... It's #BlueMonday again. And this is all you'll ever need to read to know the 'truth' about it Which is that it's a ridiculous marketing stunt that got way out of hand and impacted me more than most people

3 good things for today: - wellies that don't leak - a new bag of Grind coffee - lots of snowdrop shoots in the garden #3goodthings

Join the next Mexa virtual hackathon to design solutions using generative AI for mental health treatment. 📅 key dates: 𝐊𝐢𝐜𝐤-𝐎𝐟𝐟 𝐄𝐯𝐞𝐧𝐭: January 24, 2024 𝐇𝐚𝐜𝐤𝐢𝐧𝐠 𝐏𝐞𝐫𝐢𝐨𝐝: January 26–29, 2024 𝐖𝐢𝐧𝐧𝐞𝐫𝐬 𝐂𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐢𝐨𝐧: February 3, 2024 Register: airtable.com/app3qpCRLWwT...

Airtable | Everyone's app platform

Airtable is a low-code platform for building collaborative apps. Customize your workflow, collaborate, and achieve ambitious outcomes. Get started for free.

airtable.com

For all women in science Eleanor Maguire should be an inspiration. Unlike Rosalind Franklin, her contribution was fully appreciated during her lifetime. So it is fitting that in 2008 she was awarded the Rosalind Franklin medal by the Royal Society. #neuroscience #psychology

Are we at a tipping point for development of new mental health interventions? www.ft.com/content/134b...

The new tech treatments that could improve mental health

[FREE TO READ] From video games to personal avatars, researchers are looking to develop a new generation of digital tools that do not involve taking a drug or therapy

ft.com

🔊 Calling all digital mental health founders KHP Ventures have launched an Innovations in Mental Health Fund. To be part of the associated Immersion Programme follow www.innovationsinmentalhealth.com Webinars tomorrow 17th December at 12 and 4:30pm GMT. Apply before 9am on 7th January 2025 🧪

Innovations in Mental Health

innovationsinmentalhealth.com

Julia Gillard: ‘Researchers need to be active, vocal, engaged’ www.researchprofessionalnews.com/rr-news-uk-v...

Julia Gillard: ‘Researchers need to be active, vocal, engaged’ - Research Professional News

Amid the current turmoil, science can bring hope as well as progress, says Australian ex-PM

researchprofessionalnews.com

Made my morning!

Love my new mug

MEXA are holding a virtual hackathon on the theme of Mental Health and AI:Measurement. Dates - 3-5th December 2024 Registration closes 24th November 2024 📩 Register now at buff.ly/4fs7S7Y Join MEXA at: mexa.app Funded by Wellcome

Airtable | Everyone's app platform

Airtable is a low-code platform for building collaborative apps. Customize your workflow, collaborate, and achieve ambitious outcomes. Get started for free.

buff.ly

Word of this morning is ‘procaffeinate’: to put everything on hold until you’ve had sufficient amounts of coffee.

Disappointing results for AbbVie with their phase II schizophrenia candidate. Looks like strong placebo response was at play in at least one trial. www.fiercebiotech.com/biotech/abbv...

AbbVie's $9B schizophrenia prospect flunks phase 2 trials, handing advantage to BMS

The drug candidate at the center of AbbVie’s $8.7 billion acquisition of Cerevel Therapeutics has

fiercebiotech.com

AVATAR therapy shown to reduce distress associated with hearing voices in people living with psychosis. nature.com/articles/s41... Wellcome is committed to supporting development of new and improved interventions for anxiety, depression and psychosis - wellcome.org/news/avatar-... 🧪

Digital AVATAR therapy for distressing voices in psychosis: the phase 2/3 AVATAR2 trial - Nature Medicine

A randomized controlled trial involving people with psychosis who hear distressing voices reported that two different forms of AVATAR therapy, an intervention where voice-hearers engage with a digital...

nature.com

FDA approval of COBENFY could be game changing for schizophrenia treatment news.bms.com/news/corpora...

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults

COBENFY represents the first new pharmacological approach to treat schizophrenia in decades, with a mechanism of action distinct from current therapies Approval is supported by data from the EMERGENT ...

news.bms.com

Beautiful morning

What a life! A mid-afternoon snooze - if only!